Sarah Hughes to Coronary Artery Disease
This is a "connection" page, showing publications Sarah Hughes has written about Coronary Artery Disease.
Connection Strength
0.016
-
Brothers CH, Hernandez JE, Cutrell AG, Curtis L, Ait-Khaled M, Bowlin SJ, Hughes SH, Yeo JM, Lapierre DH. Risk of myocardial infarction and abacavir therapy: no increased risk across 52 GlaxoSmithKline-sponsored clinical trials in adult subjects. J Acquir Immune Defic Syndr. 2009 May 01; 51(1):20-8.
Score: 0.016